These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2991215)

  • 21. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Acetylpyridine thiocarbonohydrazones. Potent inactivators of herpes simplex virus ribonucleotide reductase.
    Blumenkopf TA; Harrington JA; Koble CS; Bankston DD; Morrison RW; Bigham EC; Styles VL; Spector T
    J Med Chem; 1992 Jun; 35(12):2306-14. PubMed ID: 1319497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.
    Spector T; Averett DR; Nelson DJ; Lambe CU; Morrison RW; St Clair MH; Furman PA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4254-7. PubMed ID: 2987969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agents.
    Crenshaw TR; Cory JG
    Int J Oncol; 1999 Sep; 15(3):487-90. PubMed ID: 10427129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A series of N-carbamoyloxyurea resistant cell lines with alterations in ribonucleotide reductase: lack of coordination in pyrimidine and purine reductase activity.
    Hards RG; Wright JA
    Can J Biochem Cell Biol; 1983; 61(2-3):120-9. PubMed ID: 6342725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
    Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
    Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine free radical of the enzyme in an oxygen-requiring reaction.
    Thelander L; Gräslund A
    J Biol Chem; 1983 Apr; 258(7):4063-6. PubMed ID: 6300073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4'- azido-Phe6] HSV H2-6(6-15), to subunit 1.
    Paradis H; Gaudreau P; Brazeau P; Langelier Y
    J Biol Chem; 1988 Nov; 263(31):16045-50. PubMed ID: 2846533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.
    Spector T; Stonehuerner JG; Biron KK; Averett DR
    Biochem Pharmacol; 1987 Dec; 36(24):4341-6. PubMed ID: 2825724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
    Goddard AJ; Orr RM; Stock JA; Wilman DE
    Anticancer Drug Des; 1987 Dec; 2(3):235-45. PubMed ID: 3329526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.
    Tipples G; McClarty G
    J Bacteriol; 1991 Aug; 173(16):4932-40. PubMed ID: 1860812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
    Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
    Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
    Krogsrud RL; Welchner E; Scouten E; Liuzzi M
    Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation.
    McClements W; Yamanaka G; Garsky V; Perry H; Bacchetti S; Colonno R; Stein RB
    Virology; 1988 Jan; 162(1):270-3. PubMed ID: 2827385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.
    Gaudreau P; Michaud J; Cohen EA; Langelier Y; Brazeau P
    J Biol Chem; 1987 Sep; 262(26):12413-6. PubMed ID: 3040743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2.
    Cohen EA; Gaudreau P; Brazeau P; Langelier Y
    Nature; 1986 May 22-28; 321(6068):441-3. PubMed ID: 3012360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by herpes simplex virus (HSV).
    Langelier Y; Buttin G
    J Gen Virol; 1981 Nov; 57(Pt 1):21-31. PubMed ID: 6172549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2.
    Cohen EA; Gaudreau P; Brazeau P; Langelier Y
    J Virol; 1986 Dec; 60(3):1130-3. PubMed ID: 2431161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.